Literature DB >> 30488719

Linear regression analysis of silychristin A, silybin A and silybin B contents in Silybum marianum.

Sameh F AbouZid1, Hayam S Ahmed1, Abd-El Mageed A Abd El Mageed1, Abeer S Moawad1, Asmaa I Owis1, Shao-Nong Chen2,3, Amandine Nachtergael3, James B McAlpine3, J Brent Friesen3,4, Guido F Pauli2,3.   

Abstract

Quantitative correlations between the contents of the flavonolignans silychristin A and silybins A/B provide biosynthetic clues that support a pathway in which one mesomeric form of a taxifolin radical is undergoing an oxidative coupling with a coniferyl alcohol radical. The flavonolignan content and patterns reported in the literature for 53 samples, representing populations of the Silybum marianum plant growing in different parts of the world, were subject to a meta-analysis. Linear regression analyses were carried out on these data sets, and a mathematical model was derived that predicts the content of silychristin A relative to the metabolomic pattern of its congeners. The validity of the model was verified by applying it to test samples. This approach could potentially become a tool to enhance the understanding of both the relative composition of the silymarin complex and the biosynthetic pathways that underlie its formation.

Entities:  

Keywords:  Flavonolignan; linear regression; prediction; quantitative biosynthesis modelling

Mesh:

Substances:

Year:  2018        PMID: 30488719     DOI: 10.1080/14786419.2018.1527838

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  2 in total

Review 1.  Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Lina Tao; Xiaoyu Qu; Yue Zhang; Yanqing Song; Si-Xi Zhang
Journal:  Can J Gastroenterol Hepatol       Date:  2019-01-10

2.  Liver Protection Mechanism and Absorption Promotion Technology of Silybin Based on Intelligent Medical Analysis.

Authors:  Bingbing Yan; Chuanying Zhang
Journal:  J Healthc Eng       Date:  2021-07-03       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.